These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 39054955)

  • 1. ABT‑737 increases cisplatin sensitivity through the ROS‑ASK1‑JNK MAPK signaling axis in human ovarian cancer cisplatin‑resistant A2780/DDP cells.
    Li X; Guo Y; Xing Z; Gong T; Yang L; Yang T; Chang B; Wang X; Yu B; Guo R
    Oncol Rep; 2024 Sep; 52(3):. PubMed ID: 39054955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABT737 reverses cisplatin resistance by targeting glucose metabolism of human ovarian cancer cells.
    Xu Y; Gao W; Zhang Y; Wu S; Liu Y; Deng X; Xie L; Yang J; Yu H; Su J; Sun L
    Int J Oncol; 2018 Sep; 53(3):1055-1068. PubMed ID: 30015875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABT737 induces mitochondrial pathway apoptosis and mitophagy by regulating DRP1-dependent mitochondrial fission in human ovarian cancer cells.
    Yu Y; Xu L; Qi L; Wang C; Xu N; Liu S; Li S; Tian H; Liu W; Xu Y; Li Z
    Biomed Pharmacother; 2017 Dec; 96():22-29. PubMed ID: 28963947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oridonin effectively reverses cisplatin drug resistance in human ovarian cancer cells via induction of cell apoptosis and inhibition of matrix metalloproteinase expression.
    Ma S; Tan W; Du B; Liu W; Li W; Che D; Zhang G
    Mol Med Rep; 2016 Apr; 13(4):3342-8. PubMed ID: 26935490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABT737 enhances ovarian cancer cells sensitivity to cisplatin through regulation of mitochondrial fission via Sirt3 activation.
    Hou L; Wang R; Wei H; Li S; Liu L; Lu X; Yu H; Liu Z
    Life Sci; 2019 Sep; 232():116561. PubMed ID: 31247208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl2 inhibitor ABT737 reverses the Warburg effect via the Sirt3-HIF1α axis to promote oxidative stress-induced apoptosis in ovarian cancer cells.
    Dong D; Dong Y; Fu J; Lu S; Yuan C; Xia M; Sun L
    Life Sci; 2020 Aug; 255():117846. PubMed ID: 32470451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABT737 reverses cisplatin resistance by regulating ER-mitochondria Ca2+ signal transduction in human ovarian cancer cells.
    Xie Q; Su J; Jiao B; Shen L; Ma L; Qu X; Yu C; Jiang X; Xu Y; Sun L
    Int J Oncol; 2016 Dec; 49(6):2507-2519. PubMed ID: 27748803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of MACC1 expression increases cisplatin sensitivity in cisplatin-resistant epithelial ovarian cancer cells.
    Zhang R; Shi H; Ren F; Li X; Zhang M; Feng W; Jia Y
    Oncol Rep; 2016 Apr; 35(4):2466-72. PubMed ID: 26794135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversing chemoresistance in cisplatin-resistant human ovarian cancer cells: a role of c-Jun NH2-terminal kinase 1.
    Li F; Meng L; Zhou J; Xing H; Wang S; Xu G; Zhu H; Wang B; Chen G; Lu YP; Ma D
    Biochem Biophys Res Commun; 2005 Oct; 335(4):1070-7. PubMed ID: 16105650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interference with the expression of β-catenin reverses cisplatin resistance in A2780/DDP cells and inhibits the progression of ovarian cancer in mouse model.
    Zhao H; Wei W; Sun Y; Gao J; Wang Q; Zheng J
    DNA Cell Biol; 2015 Jan; 34(1):55-62. PubMed ID: 25211326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin in combination with cisplatin induces the apoptosis of ovarian cancer cells via p53 and JNK activation.
    Zhao T; Bai J; Zou Q; Chen F; Xie Y
    Mol Med Rep; 2017 Dec; 16(6):9095-9101. PubMed ID: 29039558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to chemotherapy-induced apoptosis via decreased caspase-3 activity and overexpression of antiapoptotic proteins in ovarian cancer.
    Yang X; Zheng F; Xing H; Gao Q; Wei W; Lu Y; Wang S; Zhou J; Hu W; Ma D
    J Cancer Res Clin Oncol; 2004 Jul; 130(7):423-8. PubMed ID: 15156398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interference with SMO increases chemotherapy drug sensitivity of A2780/DDP cells by inhibiting the Hh/Gli signaling pathway.
    Ma S; Liu D; Tan W; Du B; Liu W; Li W; Jiao Y
    J Cell Biochem; 2020 Jun; 121(5-6):3256-3265. PubMed ID: 31904145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAZ Regulates the Cisplatin Resistance of Epithelial Ovarian Cancer Cells via the ANGPTL4/SOX2 Axis.
    Li C; Wang Q; Luo Y; Xiang J
    Anal Cell Pathol (Amst); 2022; 2022():5632164. PubMed ID: 36247876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-Targeted Zeolitic Imidazolate Frameworks Drug Delivery System Reversing Cisplatin Resistance to Treat Resistant Ovarian Cancer.
    Xing Y; Jing R; Tang X; Jiang Z
    Int J Nanomedicine; 2024; 19():6603-6618. PubMed ID: 38979533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tubeimoside I sensitizes cisplatin in cisplatin-resistant human ovarian cancer cells (A2780/DDP) through down-regulation of ERK and up-regulation of p38 signaling pathways.
    Liu HZ; Yu C; Yang Z; He JL; Chen WJ; Yin J; Li WM; Liu HT; Wang YX
    Mol Med Rep; 2011; 4(5):985-92. PubMed ID: 21687949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baohuoside I inhibits resistance to cisplatin in ovarian cancer cells by suppressing autophagy via downregulating HIF-1α/ATG5 axis.
    Zhou Y; Liu T; Wu Q; Wang H; Sun Y
    Mol Carcinog; 2023 Oct; 62(10):1474-1486. PubMed ID: 37283234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glaucocalyxin B Attenuates Ovarian Cancer Cell Growth and Cisplatin Resistance In Vitro via Activating Oxidative Stress.
    Zhang T; Xu C; Zheng P; Zhang X; Qiu C; Wu F; Chen J; Xiao Z; Zhu J; Zhang J; Zou P; Ni D
    Oxid Med Cell Longev; 2022; 2022():6324292. PubMed ID: 35251480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propofol inhibits proliferation and cisplatin resistance in ovarian cancer cells through regulating the microRNA‑374a/forkhead box O1 signaling axis.
    Sun Y; Peng YB; Ye LL; Ma LX; Zou MY; Cheng ZG
    Mol Med Rep; 2020 Mar; 21(3):1471-1480. PubMed ID: 32016462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery of miR-139-5p in Ovarian Cancer Reverses Cisplatin Resistance by Targeting C-Jun.
    Jiang Y; Jiang J; Jia H; Qiao Z; Zhang J
    Cell Physiol Biochem; 2018; 51(1):129-141. PubMed ID: 30439707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.